Source: https://www.eeoc.gov/eeoc/foia/letters/2011/ada_definition_disability.html
Timestamp: 2019-04-26 08:04:07+00:00

Document:
This is in response to your June 1, 2011 letter to General Counsel P. David Lopez asking whether paruresis is a disability under the Americans with Disabilities Act (ADA), as amended by the ADA Amendments Act of 2008 (ADAAA), and under the regulations implementing the ADAAA published by the U.S. Equal Employment Opportunity Commission (EEOC) on March 25, 2011.
According to the literature you provided, paruresis (sometimes called “shy bladder syndrome” or “bashful bladder syndrome”) is the inability to urinate in public restrooms or in close proximity to other people, or the fear of being unable to do so. Paruresis is generally considered to be an anxiety disorder, and typically is treated with cognitive-behavioral therapy. Your letter states that paruresis is also a chronic pelvic floor dysfunction. Individuals with paruresis sometimes are subjected to adverse employment actions because they are unable to pass standard tests designed to detect the illegal use of drugs, and are denied permission to take alternative tests that do not involve urination.
when a covered entity takes an action prohibited by the ADA because of an actual or perceived impairment that is not both transitory and minor (“regarded as”).
42 U.S.C. § 12102(1); 29 C.F.R. § 1630.2(g)(1). To be entitled to reasonable accommodation, such as being given the option to take alternative drug tests, an individual’s impairment must meet the first or second definition above; individuals whose impairment only meets the third definition are not legally entitled to accommodation. 42 U.S.C. § 12201(h); 29 C.F.R. § 1630.9(e).
Although the amended regulations and accompanying interpretive guidance (appendix) provide illustrative examples, those are by no means the only impairments that are considered disabilities. To the contrary, many impairments that are not specifically mentioned, including paruresis, will be disabilities if they meet any one of the three definitions above. Moreover, as a result of the ADAAA and the EEOC’s implementing regulations, it is now far easier than it previously was for individuals to demonstrate that they meet one of the definitions of “disability,” for reasons discussed below.
Under the ADAAA and the EEOC’s regulations, an individual with paruresis has a disability under the first or second definition if his or her condition substantially limits (or substantially limited in the past), one or more major life activities. 42 U.S.C. § 12102(1)(A), (B); 29 C.F.R. § 1630.2(g)(1)(i), (ii). As a result of the ADAAA, major life activities include major bodily functions, such as bladder and brain functions, and functions of the neurological and genitourinary systems. 42 U.S.C. § 12102(2)(B); 29 C.F.R. § 1630.2(i)(1)(ii). Major life activities also include activities that the EEOC and many courts recognized as major life activities prior to the ADAAA, such as caring for oneself. See 42 U.S.C. § 12102(2)(A); 29 C.F.R. § 1630.2(i)(1)(i).
Both the statute and the amended regulations state that the term “substantially limits” shall be construed broadly in favor of expansive coverage. 42 U.S.C. § 12102(4)(A); 29 C.F.R. § 1630.2(j)(1)(i). The term now requires a lower degree of functional limitation than was required prior to the ADAAA; an impairment does not need to prevent or severely or significantly restrict a major life activity to be considered “substantially limiting.” ADA Amendments Act of 2008, Pub. L. No. 110-325, § 2(b)(4), (6), 122 Stat. 3553 (2008); 29 C.F.R. § 1630.2(j)(1)(ii), (iv)–(v).
In addition, the determination of whether an impairment substantially limits a major life activity must be made without regard to the ameliorative effects of mitigating measures (with the exception of “ordinary eyeglasses or contact lenses”). 42 U.S.C. § 12102(4)(E); 29 C.F.R. § 1630.2(j)(1)(vi). Thus, an individual’s paruresis substantially limits a major life activity if it would do so in the absence of treatment, including cognitive-behavioral therapy and medication.
The statute and regulations also state that an impairment that is episodic or in remission is a disability if it would substantially limit a major life activity when active. 42 U.S.C. § 12102(4)(D); 29 C.F.R. § 1630.2(j)(1)(vii). Therefore, the determination of whether an individual’s paruresis substantially limits a major life activity is based on the limitations imposed by the condition when its symptoms are present (disregarding any mitigating measures that might limit or eliminate the symptoms).
However, as noted above, an individual who is covered only under the “regarded as” definition of “disability” is not entitled to a reasonable accommodation. 29 C.F.R. § 1630.9(e). Thus, someone who needs a reasonable accommodation for paruresis (e.g., to be permitted to take a hair, saliva, or patch test intended to detect the illegal use of drugs rather than a urine test) would need to demonstrate that his or her paruresis constitutes either an actual or record of disability. In addition, an employer determining if it must grant a request to take an alternative drug test will be able to consider whether such a test would cause an “undue hardship,” which may include whether an alternative test is an effective means of determining current illegal use of drugs.
1 The question of whether someone with paruresis is regarded as having a disability is separate from the question of whether an employer’s action is lawful. For example, an employer may exclude someone from a job because of an impairment if the impairment renders the individual unable to perform a job’s essential functions or if the impairment poses a direct threat (i.e., a significant risk of substantial harm) to the individual or others in the workplace.
This page was last modified on August 23, 2011.

References: § 12102
 § 1630
 § 12201
 § 1630
 § 12102
 § 1630
 § 12102
 § 1630
 § 12102
 § 1630
 § 12102
 § 1630
 § 2
 § 1630
 § 12102
 § 1630
 § 12102
 § 1630
 § 1630